PROQR THERAPEUTICS NV PRQR

April 13, 2020 - 11:51pm EST by

member

						2020	2021
Price:		5.18		EPS		N/A	N/A
Shares Out. (in M):		54		P/E		N/A	N/A
Market Cap (in $M):		236		P/FCF		N/A	N/A
Net Debt (in $M):		-112		EBIT		0	0
TEV (in $M):		136		TEV/EBIT		N/A	N/A

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

show sort by

You are not eligible to view 2 messages. To gain access to more recent message posts signup free for membership.

#	AUTHOR DATE SUBJECT
6	member 3/26/21 2:23PM Re: Update? 5
I think this is a 10x multi-bagger over the next three years. You can read some of the sellside notes but the bottom line is that you got a very efficacious and safe read out that... login to read the rest 4 view available tags
5	member 3/25/21 3:05AM Update?
BlueFIN do you mind providing an update in light of yesterday's data readout? view available tags
4	member 1/21/21 10:51AM News? Stock is up 30%
The stock is up 30% on high volume - I couldn't find any news... anyone aware of anything? view available tags
3	member 12/10/20 6:43AM Peak sales
BlueFIN thank you for the idea. I was hoping to get your clarification re the valuation model in your writeup: Per the company's presentation, both LCA10 and adRP have a similar patient populations (2,000 patients). So why view available tags
1	member 12/01/20 2:38PM Update?
Could you provide an update on PRQR? view available tags

load more messages